Delivery Order SPE2DB20D1100-SPE2DB25FD9Q0
Award Date 8/8/25
Potential Completion Date 8/11/25
Potential Value $45K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count) with a firm fixed price ceiling value of $12,096.02. The delivery order, issued on November 7, 2025, with an ultimate completion date of November 10, 2025, represents a non-competitive award under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,654.69 to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120-count supply), with a firm fixed price structure and an ultimate completion date of December 15, 2025. This non-set-aside, competitively awarded contract was issued on December 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,723.78 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120-count units) on December 2, 2025, with completion expected by December 3, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,456.46 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,045.63 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count). The contract is a firm fixed price delivery order with an ultimate completion date of June 2, 2025, and represents a non-competitive award under DLA's existing pharmaceutical supply framework. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,334.50 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count). This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of September 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Contrave is an FDA-approved pharmaceutical product used for weight...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for Contrave ER 8-90 mg tablets (120-count supply) valued at $1,751.36. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by November 5, 2025. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,988.80 for Contrave ER 8-90 mg tablets (120 count) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a $5,214.68 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units). This is a firm fixed-price, non-competitive award with an ultimate completion date of September 23, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate headquarters. As a child contract, this delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $3,946.63 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120-count packages) on November 26, 2025, with a completion date of November 28, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), an enterprise-wide pharmaceutical supply vehicle valued at $999,999,999.00...